Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaoling Cheng

Showing results (121-130 of 147) with videos related to

Pageof 15
Sort By:
Apoptosis : an International Journal on Programmed Cell Death|April 27, 2024
SIRT1 regulates mitochondrial fission to alleviate high altitude hypoxia inducedcardiac dysfunction in rats via the PGC-1α-DRP1/FIS1/MFF pathwayHongbao Xu, Xiaona Song, Xiaoru Zhang, et al.
Research and Practice in Thrombosis and Haemostasis|May 6, 2026
Emicizumab prophylaxis vs immune tolerance induction in children with severe hemophilia A and inhibitors: a retrospective comparison of bleeding control, quality of life, and costZhengping Li, Qianqian Mao, Gang Li, et al.
Phytochemistry|May 9, 2023
Seven undescribed compounds from the flower heads of Helianthus annuus LJiaxuan Bai, Xianmei Piao, Yanli Wang, et al.
Archives of Biochemistry and Biophysics|June 29, 2024
Intermittent high altitude hypoxia induced liver and kidney injury leading to hyperuricemiaLingling Pu, Hongbao Xu, Zirou Wang, et al.
Annals of Hematology|September 11, 2025
Multicenter, real-world observational study of AVA therapy following ELT/HET switching in Chinese children with persistent/chronic primary ITPJingjing Liu, Zhifa Wang, Nan Wang, et al.
Thrombosis Research|March 2, 2023
The efficacy of sequential MMF-rescue-regimen to eradicate inhibitors for refractory severe hemophilia A inhibitor children in ChinaZhengping Li, Zekun Li, Jie Sun, et al.
Pediatric Investigation|December 25, 2024
Real-world use of emicizumab in Chinese children with hemophilia A: Retrospective data from a comprehensive care centerQianqian Mao, Zhenping Chen, Guoqing Liu, et al.
Thrombosis Research|March 19, 2023
Low-dose immune tolerance induction therapy in severe hemophilia a children in China: Starting earlier resulted in better inhibitor eradication outcomesZhengping Li, Jie Sun, Zekun Li, et al.
Thrombosis Research|February 5, 2023
The efficacy of the rituximab-containing rescue-regimen for severe hemophilia A inhibitor children who relapsed following successful immune tolerance induction with rituximab in ChinaZhengping Li, Zekun Li, Jie Sun, et al.
Clinical Kidney Journal|November 14, 2025
Hypoglycaemia episodes in older diabetic adults undergoing haemodialysisJinzhu Li, Qiangguo Ao, Ruiqin Zhang, et al.
Pageof 15

Showing results (121-130 of 147) with videos related to

Sort By:
Pageof 15
Apoptosis : an International Journal on Programmed Cell Death|April 27, 2024
SIRT1 regulates mitochondrial fission to alleviate high altitude hypoxia inducedcardiac dysfunction in rats via the PGC-1α-DRP1/FIS1/MFF pathwayHongbao Xu, Xiaona Song, Xiaoru Zhang, et al.
Research and Practice in Thrombosis and Haemostasis|May 6, 2026
Emicizumab prophylaxis vs immune tolerance induction in children with severe hemophilia A and inhibitors: a retrospective comparison of bleeding control, quality of life, and costZhengping Li, Qianqian Mao, Gang Li, et al.
Phytochemistry|May 9, 2023
Seven undescribed compounds from the flower heads of Helianthus annuus LJiaxuan Bai, Xianmei Piao, Yanli Wang, et al.
Archives of Biochemistry and Biophysics|June 29, 2024
Intermittent high altitude hypoxia induced liver and kidney injury leading to hyperuricemiaLingling Pu, Hongbao Xu, Zirou Wang, et al.
Annals of Hematology|September 11, 2025
Multicenter, real-world observational study of AVA therapy following ELT/HET switching in Chinese children with persistent/chronic primary ITPJingjing Liu, Zhifa Wang, Nan Wang, et al.
Thrombosis Research|March 2, 2023
The efficacy of sequential MMF-rescue-regimen to eradicate inhibitors for refractory severe hemophilia A inhibitor children in ChinaZhengping Li, Zekun Li, Jie Sun, et al.
Pediatric Investigation|December 25, 2024
Real-world use of emicizumab in Chinese children with hemophilia A: Retrospective data from a comprehensive care centerQianqian Mao, Zhenping Chen, Guoqing Liu, et al.
Thrombosis Research|March 19, 2023
Low-dose immune tolerance induction therapy in severe hemophilia a children in China: Starting earlier resulted in better inhibitor eradication outcomesZhengping Li, Jie Sun, Zekun Li, et al.
Thrombosis Research|February 5, 2023
The efficacy of the rituximab-containing rescue-regimen for severe hemophilia A inhibitor children who relapsed following successful immune tolerance induction with rituximab in ChinaZhengping Li, Zekun Li, Jie Sun, et al.
Clinical Kidney Journal|November 14, 2025
Hypoglycaemia episodes in older diabetic adults undergoing haemodialysisJinzhu Li, Qiangguo Ao, Ruiqin Zhang, et al.
Pageof 15